Genmab A (GMAB) Finished Goods (2023 - 2025)

Genmab A's Finished Goods history runs 3 years deep, the most recent figure standing at $13.0 million for Q4 2025.

• Quarterly Finished Goods rose 18.18% year-over-year to $13.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.0 million (up 18.18% YoY) and the FY2025 annual result came in at $13.0 million, up 18.18% from the prior year.
• Finished Goods was $13.0 million for Q4 2025 at Genmab A, up from $11.0 million in the prior quarter.
• Across five years, Finished Goods topped out at $13.0 million in Q4 2025 and bottomed at $9.0 million in Q4 2023.
• A 3-year average of $11.0 million and a median of $11.0 million in 2024 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2024 — Finished Goods gained 22.22% — and 2025, when it grew 18.18%.
• Genmab A's Finished Goods stood at $9.0 million in 2023, then increased by 22.22% to $11.0 million in 2024, then rose by 18.18% to $13.0 million in 2025.
• Business Quant data shows GMAB's Finished Goods at $13.0 million in Q4 2025, $11.0 million in Q4 2024, and $9.0 million in Q4 2023.